Philippines (Ilocos Norte) CARE Project, 2012-2015
External Link: Valenzuela LM, Jayme SI, Amparo ACB, Taylor LH, Dela Cruz MPZ, Licuan DA, Gamal-Bitao R and Nel LH (2017) The Ilocos Norte Communities against Rabies Exposure Elimination Project in the Philippines: Epidemiological and Economic Aspects. Front. Vet. Sci. 4:54. doi: 10.3389/fvets.2017.00054 https://doi.org/10.3389/fvets.2017.00054
Project Background
Goal: Eliminate canine-mediated human rabies in Ilocos Norte by 2015.
Stakeholders: Provincial Rabies Control Committee, Provincial Veterinary Office, Provincial Health Office, local agencies, Department of Education, local police, medical associations, and universities.
External Link: Vigilato Marco Antonio Natal, Clavijo Alfonso, Knobl Terezinha, Silva Hugo Marcelo Tamayo, Cosivi Ottorino, Schneider Maria Cristina, Leanes Luis Fernando, Belotto Albino José and Espinal Marcos Antonio 2013Progress towards eliminating canine rabies: policies and perspectives from Latin America and the CaribbeanPhil. Trans. R. Soc. B36820120143 https://doi.org/10.1098%2Frstb.2012.0143
Background
1983 Commitment: Latin America and Caribbean countries (LAC) decided to eliminate dog-transmitted rabies with strong political commitment, multinational efforts, and Pan American Health Organization (PAHO) support.
Action Plan Approval: The ‘Action Plan for the Elimination of Urban Rabies’ was approved at the 1983 I Rabies Program Directors of the Americas (REDIPRA) meeting in Guayaquil, Ecuador, and evaluated at II and III REDIPRA in 1988 and 1989.
Mass Canine Vaccination: Campaigns are crucial, with a goal to vaccinate 80% of the canine population. A 2001-2003 survey showed an average vaccination rate of 81%, with some countries like Mexico and Brazil nearing 100%.
Vaccine Production: LAC produces 51 million doses annually, mostly for Mexico and Brazil, with the largest dog populations (16 million and 25 million dogs, respectively).
Post-Exposure Prophylaxis (PEP): Widely available, about a million people (0.2%) seek health services annually for rabies exposure, with 25% receiving free prophylaxis. Between 2001-2003, 25.4% of dog bite victims received PEP, varying from 3.2% in Cuba to 58.4% in Brazil.
Laboratories and Testing: LAC has 141 decentralized labs testing over 74,000 samples annually for rabies.
Program Impact
Success Indicators: Nearly 90% decrease in human and canine rabies incidence; elimination of canine rabies in many countries.
Case Reduction: From 1980 to 2010, dog rabies cases dropped from 25,000 to less than 300, and human deaths from dog rabies decreased from 350 to less than 10.
SIRVERA Data: From 2000-2008, an average of 25 dog-transmitted rabies cases were recorded annually in seven countries. In the last three years, only seven countries reported human rabies cases from dogs.
Areas for Improvement
Endemic Regions: Rabies remains endemic in Haiti and Bolivia and sporadically in Cuba, Nicaragua, Venezuela, and parts of Central America and Brazil.
Localized Cases: Rabies cases are highly localized, affecting 0.2% of second-level communities, mostly in low-income areas on city outskirts.
PEP Challenges: Ensuring immunoglobulin administration to seriously exposed bite-victims is a challenge; over a third of LAC countries did not meet this requirement until 2004.
Vaccine Quality: The shift to more potent, safe, and effective cell-culture vaccines for humans is needed; some countries still use older, riskier vaccines.
Continuous Transmission Areas: Areas with ongoing transmission include Haiti, Cuba, Nicaragua, Colombia, Ecuador, Venezuela, northeast Brazil, and border areas of Mexico, Guatemala, Honduras, El Salvador, Bolivia, Argentina, and Peru.
Burden of Disease: Haiti and Bolivia were responsible for over half of dog-transmitted human rabies cases between 2008-2011, with the greatest burden in the past 7 years.
Websites store cookies to enhance functionality and personalise your experience. You can manage your preferences, but blocking some cookies may impact site performance and services.
Essential cookies enable basic functions and are necessary for the proper function of the website.
Name
Description
Duration
Cookie Preferences
This cookie is used to store the user's cookie consent preferences.
30 days
Cookie Preferences
This cookie is used to store the user's cookie consent preferences.
30 days
Cookie Preferences
This cookie is used to store the user's cookie consent preferences.
30 days
Cookie Preferences
This cookie is used to store the user's cookie consent preferences.
30 days
Cookie Preferences
This cookie is used to store the user's cookie consent preferences.
30 days
Cookie Preferences
This cookie is used to store the user's cookie consent preferences.
30 days
Cookie Preferences
This cookie is used to store the user's cookie consent preferences.
30 days
These cookies are needed for adding comments on this website.
Name
Description
Duration
comment_author
Used to track the user across multiple sessions.
Session
comment_author_email
Used to track the user across multiple sessions.
Session
comment_author_url
Used to track the user across multiple sessions.
Session
Google reCAPTCHA helps protect websites from spam and abuse by verifying user interactions through challenges.
Name
Description
Duration
_GRECAPTCHA
Google reCAPTCHA sets a necessary cookie (_GRECAPTCHA) when executed for the purpose of providing its risk analysis.
179 days
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Contains information related to marketing campaigns of the user. These are shared with Google AdWords / Google Ads when the Google Ads and Google Analytics accounts are linked together.
90 days
__utma
ID used to identify users and sessions
2 years after last activity
__utmt
Used to monitor number of Google Analytics server requests
10 minutes
__utmb
Used to distinguish new sessions and visits. This cookie is set when the GA.js javascript library is loaded and there is no existing __utmb cookie. The cookie is updated every time data is sent to the Google Analytics server.
30 minutes after last activity
__utmc
Used only with old Urchin versions of Google Analytics and not with GA.js. Was used to distinguish between new sessions and visits at the end of a session.
End of session (browser)
__utmz
Contains information about the traffic source or campaign that directed user to the website. The cookie is set when the GA.js javascript is loaded and updated when data is sent to the Google Anaytics server
6 months after last activity
__utmv
Contains custom information set by the web developer via the _setCustomVar method in Google Analytics. This cookie is updated every time new data is sent to the Google Analytics server.
2 years after last activity
__utmx
Used to determine whether a user is included in an A / B or Multivariate test.
18 months
_ga
ID used to identify users
2 years
_gali
Used by Google Analytics to determine which links on a page are being clicked
30 seconds
_ga_
ID used to identify users
2 years
_gid
ID used to identify users for 24 hours after last activity
24 hours
_gat
Used to monitor number of Google Analytics server requests when using Google Tag Manager